RE:Pfizer partnered Phase 3 goes South due to 3rd party CROFebruary 23, 2023 - Pfizer is ending its work with research contractor Care Access on an 18,000-patient Lyme disease vaccine trial.
https://endpts.com/pfizer-cuts-cro-unicorn-from-lyme-vaccine-trial-in-dispute-over-conduct/